A 67-year-old postmenopausal woman sustains a low-trauma Colles fracture after tripping on a step. DEXA scan shows a T-score of -2.7 at the femoral neck. Vitamin D level is adequate. She has no contraindications to bisphosphonates. What is the most appropriate pharmacological management to reduce future fracture risk?